Galvus Met Tablets 50Mg/500Mg (3 Strip = 30 Tablets)

Advanced Glycemic Control in a Single Combination Tablet

Galvus Met Tablets 50mg/500mg is a prescription oral antidiabetic medication designed to improve blood glucose control in adults with Type 2 Diabetes Mellitus (T2DM). Formulated with Vildagliptin and Metformin HCl, this fixed-dose combination targets multiple mechanisms involved in blood sugar regulation.

Each box contains three strips, with 10 tablets per strip, providing a total of 30 tablets for consistent and structured diabetes management.

How Galvus Met Works

Galvus Met combines two complementary agents to enhance glycemic control:

Vildagliptin – DPP-4 Inhibition

Vildagliptin works by inhibiting the DPP-4 enzyme. This action increases levels of incretin hormones such as GLP-1 and GIP, which help regulate insulin secretion. As a result, the body produces more insulin when blood glucose levels are high and reduces excess glucagon production.

Metformin HCl – Improved Insulin Sensitivity

Metformin decreases hepatic glucose production by inhibiting gluconeogenesis and glycogenolysis. It also reduces intestinal glucose absorption and improves peripheral glucose uptake, enhancing the body’s sensitivity to insulin.

Together, these mechanisms help control both fasting and post-meal blood glucose levels effectively.

Key Benefits of Galvus Met 50mg/500mg

1. Dual-Pathway Glucose Control

Addresses insulin secretion and insulin resistance simultaneously for comprehensive blood sugar management.

2. Improved Fasting and Postprandial Control

Helps maintain stable glucose levels throughout the day.

3. Convenient Fixed-Dose Combination

Combining Vildagliptin and Metformin in one tablet simplifies treatment and supports better adherence.

4. Adjunct to Diet and Exercise

Designed to complement lifestyle modifications for optimal diabetes management.

Who Should Use Galvus Met?

Galvus Met Tablets are indicated for adults with Type 2 Diabetes Mellitus who:

• Are inadequately controlled on Metformin alone
• Are already taking Vildagliptin and Metformin as separate tablets
• Require combination oral therapy for better glycemic control

This medication is not recommended for children and is not a substitute for insulin in patients requiring insulin therapy.

Dosage and Administration

Galvus Met 50mg/500mg is typically taken twice daily — one tablet in the morning and one in the evening — with meals to reduce gastrointestinal side effects associated with Metformin.

The maximum daily dose of Vildagliptin should not exceed 100mg. Always follow your healthcare provider’s prescribed dosage instructions.

Safety Information and Precautions

Galvus Met requires medical supervision and a valid prescription.

Do not use this medication if you:

• Have hypersensitivity to Vildagliptin or Metformin
• Have diabetic ketoacidosis or diabetic pre-coma
• Have Type 1 diabetes

Monitor for symptoms of hypoglycemia, such as dizziness, tremors, or sweating. Inform your doctor immediately if you experience signs of pancreatitis, including severe abdominal pain.

Metformin should be discontinued 48 hours before elective surgery with general anesthesia and resumed only after medical advice.

Avoid excessive alcohol consumption, as it may increase the risk of side effects.

Storage Instructions

Store Galvus Met Tablets at room temperature. Keep away from direct heat and light. Ensure the medication is stored safely out of reach of children.

Take Control of Your Diabetes Today

Effective diabetes management requires a comprehensive approach. Galvus Met Tablets 50mg/500mg provide dual-action therapy designed to improve blood sugar control and support long-term metabolic health.

Consult your healthcare provider to determine if Galvus Met is right for your treatment plan. Take a proactive step toward better glycemic control and a healthier future today.